Literature DB >> 3220507

K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors.

D M Chassoux1, L G Linares-Cruz, H Bazin, M Stanislawski.   

Abstract

Among the rat antibodies tested in this study, monoclonals of IgG2a isotype were the best, IgG1 and IgG2b being also effective, for induction of K-cell-mediated cytotoxicity of relevant nucleated target cells by rat effectors (Nude spleen cells). The single rat monoclonal IgE tested was also active. Rat antibodies of IgM and IgA classes of immunoglobulins were not active in that system. IgG2c and IgD monoclonals were not tested. Using the same panel of reagents, cytotoxicity mediated by human K cells (peripheral blood mononuclear cells) was only induced by the IgG2b class of rat monoclonals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220507      PMCID: PMC1385574     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

2.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

3.  Three classes and four (sub)classes of rat immunoglobulins: IgM, IgA, IgE and IgG1, IgG2a, IgG2b, IgG2c.

Authors:  H Bazin; A Beckers; P Querinjean
Journal:  Eur J Immunol       Date:  1974-01       Impact factor: 5.532

4.  Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.

Authors:  I C MacLennan; G E Connell; F M Gotch
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

5.  Evidence for correlation between the antigenic specificity and charge of human IgG. A study of antibody-inducing lymphocyte mediated cell damage.

Authors:  I C MacLennan; A Howard
Journal:  Immunology       Date:  1972-06       Impact factor: 7.397

6.  Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A.

Authors:  G A Medgyesi; G Füst; J Gergely; H Bazin
Journal:  Immunochemistry       Date:  1978-02

7.  Peripheral localisation of an IgE immune response at axillary lymph nodes draining the site of a local parasitic infection.

Authors:  D Chassoux; H Bazin
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

8.  Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.

Authors:  H L Spiegelberg; H Perlmann; P Perlmann
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Reshaping human antibodies for therapy.

Authors:  L Riechmann; M Clark; H Waldmann; G Winter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

10.  Specificity of fc receptors for IgG2a, IgG1/IgG2b, and IgE on rat macrophages.

Authors:  G Boltz-Nitulescu; H Bazin; H L Spiegelberg
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  2 in total

1.  Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis.

Authors:  Pablo A Silveira; Fiona Kupresanin; Adelina Romano; Wei-Hsun Hsu; Tsun-Ho Lo; Xinsheng Ju; Hsiao-Ting Chen; Helen Roberts; Daniel G Baker; Georgina J Clark
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

2.  GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma.

Authors:  Felix Zirngibl; Sara M Ivasko; Laura Grunewald; Anika Klaus; Silke Schwiebert; Peter Ruf; Horst Lindhofer; Kathy Astrahantseff; Lena Andersch; Johannes H Schulte; Holger N Lode; Angelika Eggert; Kathleen Anders; Patrick Hundsdoerfer; Annette Künkele
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.